{"protocolSection":{"identificationModule":{"nctId":"NCT00080275","orgStudyIdInfo":{"id":"019-02-03-CR"},"secondaryIdInfos":[{"id":"OCEANS"}],"organization":{"fullName":"Kos Pharmaceuticals","class":"INDUSTRY"},"briefTitle":"Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)","officialTitle":"An Open-Label Evaluation of the Safety and Efficacy of a Combination of Niacin ER and Simvastatin in Patients With Dyslipidemia (OCEANS)"},"statusModule":{"statusVerifiedDate":"2006-10","overallStatus":"COMPLETED","startDateStruct":{"date":"2004-03"},"studyFirstSubmitDate":"2004-03-25","studyFirstSubmitQcDate":"2004-03-26","studyFirstPostDateStruct":{"date":"2004-03-29","type":"ESTIMATED"},"lastUpdateSubmitDate":"2006-10-31","lastUpdatePostDateStruct":{"date":"2006-11-01","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"leadSponsor":{"name":"Kos Pharmaceuticals","class":"INDUSTRY"}},"descriptionModule":{"briefSummary":"The purpose of this 24 week study is to compare the effectiveness and safety of different doses of Niacin ER/Simvastatin (NS) in subjects with elevated fat levels in their blood (dyslipidemia).\n\nAt least 600 subjects with a similar medical condition will take part in this study.","detailedDescription":"Objectives:\n\nTo evaluate the safety and efficacy of the combination product niacin ER and simvastatin (NS) in patients with primary type II dyslipidemia and to descriptively compare flushing rates between two Titration Schedules for NS."},"conditionsModule":{"conditions":["Hypercholesterolemia"],"keywords":["Niacin","Statin","Zocor","Simvastatin","Coronary Heart Disease","Dyslipidemia","Atherosclerosis","Hypercholesterolemia","Stroke","High-Density Lipoprotein Cholesterol","Low-Density Lipoprotein Cholesterol","Lipoprotein","Lipid","Niacin ER/simvastatin","Total Cholesterol","Triglycerides"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":600}},"armsInterventionsModule":{"interventions":[{"type":"DRUG","name":"Niacin Extended-Release and simvastatin Tablets"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient has primary Type II hyperlipidemia or mixed dyslipidemia.\n* If the patient is currently taking a lipid modifying medication other than Zocor \\& he/she is willing to discontinue this medication\n* LDL-C levels and/or non HDL-C levels above normal.\n* Reasonable compliance with a standard cholesterol-lowering diet for a minimum of 4 weeks prior to screening and for the duration of the study.\n\nExclusion Criteria:\n\n* Patient has an allergy, hypersensitivity, or intolerance to niacin, statins, or their derivatives.\n* HbA1c â‰¥ 9% in diabetic patients","healthyVolunteers":false,"sex":"ALL","minimumAge":"21 Years","stdAges":["ADULT","OLDER_ADULT"]},"referencesModule":{"references":[{"pmid":"18422390","type":"DERIVED","citation":"Karas RH, Kashyap ML, Knopp RH, Keller LH, Bajorunas DR, Davidson MH. Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study. Am J Cardiovasc Drugs. 2008;8(2):69-81. doi: 10.2165/00129784-200808020-00001."}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14","removedCountries":["United States"]},"conditionBrowseModule":{"meshes":[{"id":"D000006937","term":"Hypercholesterolemia"},{"id":"D000050171","term":"Dyslipidemias"}],"ancestors":[{"id":"D000006949","term":"Hyperlipidemias"},{"id":"D000052439","term":"Lipid Metabolism Disorders"},{"id":"D000008659","term":"Metabolic Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M6236","name":"Coronary Artery Disease","relevance":"LOW"},{"id":"M6239","name":"Coronary Disease","relevance":"LOW"},{"id":"M25871","name":"Dyslipidemias","asFound":"Dyslipidemia","relevance":"HIGH"},{"id":"M19196","name":"Myocardial Ischemia","relevance":"LOW"},{"id":"M25878","name":"Atherosclerosis","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"},{"id":"M9678","name":"Hypercholesterolemia","asFound":"Hypercholesterolemia","relevance":"HIGH"},{"id":"M9690","name":"Hyperlipidemias","relevance":"LOW"},{"id":"M9692","name":"Hyperlipoproteinemias","relevance":"LOW"},{"id":"M11329","name":"Metabolic Diseases","relevance":"LOW"},{"id":"M26719","name":"Lipid Metabolism Disorders","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC18","name":"Nutritional and Metabolic Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D000009525","term":"Niacin"},{"id":"D000019821","term":"Simvastatin"}],"ancestors":[{"id":"D000000924","term":"Anticholesteremic Agents"},{"id":"D000000960","term":"Hypolipidemic Agents"},{"id":"D000000963","term":"Antimetabolites"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000057847","term":"Lipid Regulating Agents"},{"id":"D000019161","term":"Hydroxymethylglutaryl-CoA Reductase Inhibitors"},{"id":"D000004791","term":"Enzyme Inhibitors"},{"id":"D000014665","term":"Vasodilator Agents"},{"id":"D000014803","term":"Vitamin B Complex"},{"id":"D000014815","term":"Vitamins"},{"id":"D000018977","term":"Micronutrients"},{"id":"D000045505","term":"Physiological Effects of Drugs"}],"browseLeaves":[{"id":"M12166","name":"Niacinamide","relevance":"LOW"},{"id":"M12155","name":"Niacin","asFound":"No treatment","relevance":"HIGH"},{"id":"M12169","name":"Nicotinic Acids","relevance":"LOW"},{"id":"M21403","name":"Simvastatin","asFound":"Elderly","relevance":"HIGH"},{"id":"M20845","name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","relevance":"LOW"},{"id":"M3933","name":"Anticholesteremic Agents","relevance":"LOW"},{"id":"M3968","name":"Hypolipidemic Agents","relevance":"LOW"},{"id":"M3971","name":"Antimetabolites","relevance":"LOW"},{"id":"M28573","name":"Lipid Regulating Agents","relevance":"LOW"},{"id":"M7641","name":"Enzyme Inhibitors","relevance":"LOW"},{"id":"M17102","name":"Vasodilator Agents","relevance":"LOW"},{"id":"M17248","name":"Vitamins","relevance":"LOW"},{"id":"M8308","name":"Folic Acid","relevance":"LOW"},{"id":"M17236","name":"Vitamin B Complex","relevance":"LOW"},{"id":"M20699","name":"Micronutrients","relevance":"LOW"},{"id":"M16575","name":"Trace Elements","relevance":"LOW"},{"id":"T455","name":"Nicotinamide","relevance":"LOW"},{"id":"T453","name":"Niacin","asFound":"No treatment","relevance":"HIGH"},{"id":"T454","name":"Niacinamide","relevance":"LOW"},{"id":"T456","name":"Nicotinic Acid","relevance":"LOW"},{"id":"T471","name":"Vitamin B3","relevance":"LOW"},{"id":"T446","name":"Folic Acid","relevance":"LOW"},{"id":"T448","name":"Folate","relevance":"LOW"},{"id":"T475","name":"Vitamin B9","relevance":"LOW"}],"browseBranches":[{"abbrev":"Micro","name":"Micronutrients"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"VaDiAg","name":"Vasodilator Agents"},{"abbrev":"Lipd","name":"Lipid Regulating Agents"},{"abbrev":"Hemat","name":"Hematinics"},{"abbrev":"Vi","name":"Vitamins"}]}},"hasResults":false}